Medical equipment and services company Steris (NYSE:STE). fell short of the market’s revenue expectations in Q4 CY2024, but ...

Medical tech company CONMED (NYSE:CNMD) announced better-than-expected revenue in Q4 CY2024, with sales up 5.8% year on year ...

Altria Group reported robust Q4 earnings, driven by NJOY's alternative products growth. Click here to see why MO stock is a ...

Option activity in these three fallen angel stocks has ticked up lately, and the shares could be ready to follow along for the ride.

Altria held its fourth-quarter 2024 earnings call on Thursday. The tobacco company reported net revenues for the fourth quarter were essentially unchanged from fourth-quarter 2023 at $6.0 billion.

A Belfast-based medical products distributor has been sold to a Scandinavian trade buyer in a deal which provides an exit for private equity and infrastructure investment manager Foresight Group.

AbbVie, Vertex Pharmaceuticals, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to ...

The Peptide Synthesis market valued at US$ 0.78 Billion in 2023, is forecasted to grow at a robust CAGR of 11.7%, reaching US$ 0.81 Billion in ...

Q4 2024 Earnings Call February 5, 2025 8:00 AM ETCompany ParticipantsPeter Pudselykke - Head, Investor RelationsSøren Nielsen ...

Canada is facing big bully threats. Cory Doctorow (a Canadian) says retaliatory tariffs are not the right response. He says, ...

Private equity firm Foresight Group has exited its investment in Belfast-based medical products distributor Hospital Services ...

Minnetronix Medical — one of 500 medical device companies based in Minnesota — isn’t expecting a major impact from the Trump ...